Patent: 8,017,733
✉ Email this page to a colleague
Summary for Patent: 8,017,733
| Title: | Polyalkylene polymer compounds and uses thereof |
| Abstract: | The invention relates to novel polyalkylene glycol compounds and methods of using them. In particular, compounds comprising a novel polyethylene glycol conjugate are used alone, or in combination with antiviral agents to treat a viral infection, such as chronic hepatitis C. |
| Inventor(s): | KoChung Lin, R. Blake Pepinsky, Ling Ling Chen, Donna M. Hess, Edward Y. Lin, Russell C. Petter, Darren P. Baker |
| Assignee: | Biogen MA Inc |
| Application Number: | US10/892,830 |
| Patent Claims: | see list of patent claims |
Details for Patent 8,017,733
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Emd Serono, Inc. | REBIF | interferon beta-1a | Injection | 103780 | 7-Mar-02 | 8,017,733 | 2024-07-16 |
| Emd Serono, Inc. | REBIF | interferon beta-1a | Injection | 103780 | 17-Dec-04 | 8,017,733 | 2024-07-16 |
| Emd Serono, Inc. | REBIF | interferon beta-1a | Injection | 103780 | 21-Dec-12 | 8,017,733 | 2024-07-16 |
| Biogen Inc. | PLEGRIDY | peginterferon beta-1a | Injection | 125499 | 15-Aug-14 | 8,017,733 | 2024-07-16 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
